Biofrontera AG Sponsored ADR Research and Development (R&D) Expenses Growth

Research and Development (R&D) Expenses Growth of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Research and Development (R&D) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Research and Development (R&D) Expenses Growth for the quarter ending June 30, 2022 was -16.37% (a -224.49% decrease compared to previous quarter)
  • Year-over-year quarterly Research and Development (R&D) Expenses Growth decreased by -127.91%
  • Annual Research and Development (R&D) Expenses Growth for 2021 was -3.4% (a -105.97% decrease from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2021 was 56.91% (a 2213.41% increase from previous year)
  • Annual Research and Development (R&D) Expenses Growth for 2020 was 2.46% (a -13.07% decrease from previous year)
  • Twelve month Research and Development (R&D) Expenses Growth ending June 30, 2022 was 26.8% (a -43.97% decrease compared to previous quarter)
  • Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -11.67% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
26.8% 47.83% 47.84% 30.34%
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Research and Development (R&D) Expenses Growth of Biofrontera AG Sponsored ADR

Most recent Research and Development (R&D) Expenses Growthof BFAGY including historical data for past 10 years.

Interactive Chart of Research and Development (R&D) Expenses Growth of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -16.37% 13.15%
2021 65.56% 58.66% 57.65% 9.78% -3.4%
2020 7.19% 19.24% -1.99% 20.62% 2.46%
2019 29.66% -17.24% 2.03% -1.02%
2018 -17.09% 13.27%
2017 -22.88% 20.83% 28.96%
2016 19.55%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic